Joseph Baroldi Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 9 hours ago
Joseph Baroldi has an estimated net worth of at least $10.4 million*, as of June 24, 2026. They own 49,256 shares of IONS stock. They have sold 113,159 shares of IONS stock since 2021, for an estimated $6.6 million.
Joseph Baroldi $IONS SEC Form 4 Insider Trading
Joseph Baroldi has filed a total of 25 insider trades in $IONS since 2021. Their most recent trade was a sale of 5,635 shares, made on Jun 26, 2026. Their largest trade was a sale of 30,000 shares, made on Sep 03, 2025. We estimate that they now own 49,256 shares of $IONS, worth an estimated $3.8 million.
Insider Trading at $IONS
There have been a total of 308 insider trades reported at $IONS since 2021, with 20,000 shares purchased and 3.3 million shares sold. The most active insider traders in $IONS stock have been Brett P Monia, Eric Swayze, and Patrick R. O'Neil. The most recent trade was a sale of 5,635 shares reported by Joseph Baroldi (EVP, Chief Business Officer), made on Jun 26, 2026.
History of Insider Stock Trades by Joseph Baroldi
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
IONS
|
Sale | 5,635 | Jun 26, 2026 | June 30, 2026, 5:48 p.m. |
|
IONS
|
Sale | 1,626 | Apr 28, 2026 | April 30, 2026, 4:21 p.m. |
|
IONS
|
Sale | 5,619 | Apr 16, 2026 | April 17, 2026, 7:19 p.m. |
|
IONS
|
Sale | 36 | Mar 03, 2026 | March 5, 2026, 7:13 p.m. |
|
IONS
|
Sale | 2,088 | Mar 03, 2026 | March 5, 2026, 7:13 p.m. |
|
IONS
|
Sale | 4,096 | Mar 03, 2026 | March 5, 2026, 7:13 p.m. |
|
IONS
|
Sale | 201 | Mar 04, 2026 | March 5, 2026, 7:13 p.m. |
|
IONS
|
Sale | 238 | Mar 04, 2026 | March 5, 2026, 7:13 p.m. |
|
IONS
|
Sale | 5,296 | Jan 30, 2026 | Feb. 2, 2026, 9:51 p.m. |
|
IONS
|
Sale | 6,907 | Jan 16, 2026 | Jan. 20, 2026, 9:18 p.m. |
|
IONS
|
Sale | 1,149 | Jan 16, 2026 | Jan. 20, 2026, 9:18 p.m. |
|
IONS
|
Sale | 1,625 | Oct 06, 2025 | Oct. 8, 2025, 6:36 p.m. |
|
IONS
|
Sale | 15,000 | Oct 02, 2025 | Oct. 2, 2025, 7:35 p.m. |
|
IONS
|
Sale | 11,950 | Sep 09, 2025 | Sept. 11, 2025, 5:05 p.m. |
|
IONS
|
Sale | 250 | Sep 05, 2025 | Sept. 9, 2025, 6:30 p.m. |
|
IONS
|
Sale | 30,000 | Sep 03, 2025 | Sept. 4, 2025, 8:34 p.m. |
|
IONS
|
Sale | 2,800 | Sep 03, 2025 | Sept. 4, 2025, 8:34 p.m. |
|
IONS
|
Sale | 3,928 | Apr 16, 2025 | April 17, 2025, 4:53 p.m. |
|
IONS
|
Sale | 3,401 | Jan 16, 2025 | Jan. 17, 2025, 8:40 p.m. |
|
IONS
|
Sale | 1,029 | Jan 16, 2025 | Jan. 17, 2025, 8:40 p.m. |
|
IONS
|
Sale | 4,006 | Apr 16, 2024 | April 17, 2024, 5:19 p.m. |
|
IONS
|
Sale | 564 | Jan 17, 2024 | Jan. 18, 2024, 6:44 p.m. |
|
IONS
|
Sale | 1,460 | Jan 17, 2024 | Jan. 18, 2024, 6:44 p.m. |
|
IONS
|
Sale | 3,880 | Apr 18, 2023 | April 19, 2023, 8:18 p.m. |
|
IONS
|
Sale | 375 | Jan 18, 2023 | Jan. 19, 2023, 9:19 p.m. |
$IONS Executives and Stock Owners with Insider Trades
-
Brett P Monia, Chief Executive Officer
-
Eric Swayze, EVP Research
-
Patrick R. O'Neil, EVP CLO & General Counsel
-
Joseph Baroldi, EVP, Chief Business Officer
-
Richard S Geary, EVP, Chief Development Officer
-
C Frank Bennett, EVP, Chief Scientific Officer
-
Shannon L. Devers, EVP, Chief Human Resources Ofc
-
Eugene Schneider, EVP, Chf Clinical Develop Ofcr
-
Elizabeth L Hougen, EVP, Finance & CFO
-
Brian Birchler, EVP, Corp and Development Ops
-
Onaiza Cadoret-Manier, EVP, Chf GL Pdt Str & Oper Ofc
-
Holly B. Kordasiewicz, EVP, Chief Development Officer
-
Kyle Jenne, EVP, Chf GL Pdt Str Ofcr
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.